Jinhua Qinggan Granules in the Treatment of COVID-19

Inclusion Criteria: * 1\) Between the ages of 18-75 years, both male and female. * 2\) Confirmed Coronavirus infection by real time RT-PCR. * 3\) Mild cases of Coronavirus having main symptoms with minimum 2 grade (as mentioned in 7.1.6). * 4\) The subject has signed the informed consent form; Exclusion Criteria: * 1\) Younger than 18 years or older than 75 years. * 2\) Patients with moderate or critical Coronavirus infection confirmed by real time RT-PCR; cases meeting any of the following criteria: 1. Lung lesions 2. Respiratory failure and requiring mechanical ventilation 3. Shock 4. With other organ failure that requires ICU cares. * 3\) Severe primary health conditions associated with cardiovascular, cerebrovascular, pulmonary, hepatic, renal, endocrine and hematological diseases, hematopoietic system (above grade II of cardiac function; ALT \& AST are 1.5 times higher than the normal value; Creatinine above the upper limit of normal value) and mental illness or serious diseases affecting their survival, such as cancer or AIDS; * 4\) With severe cardiopulmonary dysfunction, cardiopulmonary insufficiency. * 5\) Subjects, who took other antiviral, antibacterial, cough relieving, expectorant and antiasthmatic drugs within 3 days prior to the visit (including β2 receptor agonists, anticholinergic agents, theophylline drugs, glucocorticoids, expectorant and Chinese Medicine.) * 6\) Allergic individuals and those who are known to be allergic to experimental drugs * 7\) Pregnant women, lactating women or fertile women who are ready to conceive in 3 months. * 8\) Subject, who has participated in the past 1 month in another clinical study. * 9\) Subjects who are not suitable for the clinical trial based on investigators' judgment.